Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies
Open Access
- 22 May 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-20
Abstract
The δ-opioid receptor (DOP) is an attractive pharmacological target due to its potent analgesic, anxiolytic and anti-depressant activity in chronic pain models. However, some but not all selective DOP agonists also produce severe adverse effects such as seizures. Thus, the development of novel agonists requires a profound understanding of their effects on DOP phosphorylation, post-activation signaling and dephosphorylation. Here we show that agonist-induced DOP phosphorylation at threonine 361 (T361) and serine 363 (S363) proceeds with a temporal hierarchy, with S363 as primary site of phosphorylation. This phosphorylation is mediated by G protein-coupled receptor kinases 2 and 3 (GRK2/3) followed by DOP endocytosis and desensitization. DOP dephosphorylation occurs within minutes and is predominantly mediated by protein phosphatases (PP) 1α and 1β. A comparison of structurally diverse DOP agonists and clinically used opioids demonstrated high correlation between G protein-dependent signaling efficacies and receptor internalization. In vivo, DOP agonists induce receptor phosphorylation in a dose-dependent and agonist-selective manner that could be blocked by naltrexone in DOP-eGFP mice. Together, our studies provide novel tools and insights for ligand-activated DOP signaling in vitro and in vivo and suggest that DOP agonist efficacies may determine receptor post-activation signaling.Keywords
Funding Information
- Interdisziplinäres Zentrum für klinische Forschung J61
- Deutsche Forschungsgemeinschaft (SCHU924/8-1, SFB/TR166-TPC5)
This publication has 142 references indexed in Scilit:
- Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to humanBritish Journal of Pharmacology, 2011
- Delta opioid receptor analgesiaBehavioural Pharmacology, 2011
- Rapid Dephosphorylation of G Protein-coupled Receptors by Protein Phosphatase 1β Is Required for Termination of β-Arrestin-dependent SignalingJournal of Biological Chemistry, 2011
- Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodiesBritish Journal of Pharmacology, 2011
- The Therapeutic Potential of κ-Opioids for Treatment of Pain and AddictionNeuropsychopharmacology, 2010
- PRECLINICAL STUDY: Modulation of MDMA‐induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in miceAddiction Biology, 2009
- Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat PainCell, 2009
- From Promiscuity to Precision: Protein Phosphatases Get a MakeoverMolecular Cell, 2009
- Augmentation of Morphine-Induced Sensitization but Reduction in Morphine Tolerance and Reward in Delta-Opioid Receptor Knockout MiceNeuropsychopharmacology, 2008
- Knockin mice expressing fluorescent δ-opioid receptors uncover G protein-coupled receptor dynamicsinvivoProceedings of the National Academy of Sciences, 2006